Last reviewed · How we verify
NCT03524079: RV-BrS
Right Ventricle Morphology and Hemodynamics in BrS
trial testing Ajmaline 17-(Chloroacetate) Monohydrochloride in Brugada Syndrome in 60 participants. Completed in 9 November 2019.
8 November 2019
Quick facts
| Lead sponsor | IRCCS Policlinico S. Donato |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 19 April 2018 |
| Primary completion | 8 November 2019 |
| Estimated completion | 9 November 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Ajmaline 17-(Chloroacetate) Monohydrochloride — full drug profile →
Conditions studied
- Brugada Syndrome — all drugs for Brugada Syndrome →
Sponsor
IRCCS Policlinico S. Donato
Who can join
18 and older, any sex, with Brugada Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study purpose is to evaluate the morphological, functional and electrophysiological characteristics of the right ventricle before and after ajmaline in patients diagnosed with Brugada syndrome as well as to correlate CMR findings and substrate size.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03524079
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brugada Syndrome
Currently open trials in the same condition.
- NCT06546137 — National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un · recruiting
- NCT05643209 — Brugada Syndrome Substrate Characterization and Ablation · NA · recruiting
- NCT05521451 — Clinical Cohort Study - TRUST · recruiting
- NCT05685134 — Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome · NA · active not recruiting
- NCT03775954 — Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise · recruiting
Other IRCCS Policlinico S. Donato trials
Trials by the same sponsor.
- NCT07295522 — Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? · Phase 4 · not yet recruiting
- NCT07169669 — Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome · not yet recruiting
- NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
- NCT07402161 — The Signature of Alzheimer's Disease in Subjective Cognitive Decline · recruiting
- NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03524079 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Policlinico S. Donato
- Last refreshed: 18 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03524079.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing